Brief: Piramal Pharma Us FDA Conducted Pre-Approval Inspection And Good Manufacturing Practices Inspection Of Lexington Facility

Piramal Pharma (Mumbai)

11/01/2023 06:10

Jan 11 (Reuters) - Piramal Pharma Ltd  PIRM.NS :
    * US FDA CONDUCTED PRE-APPROVAL INSPECTION AND GOOD
MANUFACTURING
PRACTICES INSPECTION OF LEXINGTON FACILITY
    * AT CONCLUSION OF INSPECTION US FDA ISSUED A FORM-483 WITH
6
OBSERVATIONS
    * OBSERVATIONS CLASSIFIED UNDER VOLUNTARY ACTION INDICATED,
DOES
NOT RELATE TO DATA INTEGRITY

Source text for Eikon:  ID:nBSE1RGv6D 
Further company coverage:  PIRM.NS 
 ((Reuters.Briefs@thomsonreuters.com;))